Improving the quality of reporting of randomized controlled trials. The CONSORT statement.

Keywords

Consolidated Standards of Reporting Trials, Generalizability theory, Randomized controlled trial, Internal validity, Medicine

References

• The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials.克哉 中村, 武洋 越智, 昌昭 松尾 — 1978
• Guidelines for statistical reporting in articles for medical journals. Amplifications and explanations.John C. Bailar, FREDERICK MOSTELLER — 1988
• Quality of nonstructured and structured abstracts of original research articles in the British Medical Journal, the Canadian Medical Association Journal and the Journal of the American Medical Association.Anna Taddio, the CIHR Team in Children’s Pain, F F Fassos — 1994
• Statistical power, sample size, and their reporting in randomized controlled trials.David Moher — 1994
• Trials on trial. A review of trials of antibiotic prophylaxis.Mary Evans — 1984
• When to stop a clinical trial.Stuart Pocock — 1992
• Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals.Kenneth F. Schulz — 1994
• Randomized controlled trial of 3 vs 10 days of trimethoprim/sulfamethoxazole for acute maxillary sinusitis.John W Williams — 1995
• Statistics in practice. Comparing the means of several groups.Katherine Godfrey — 1985
• Statistical problems in the reporting of clinical trials. A survey of three medical journals.Stuart Pocock, Michael D. Hughes, Robert J. Lee — 1987
• Assessing the quality of reports of randomized clinical trials: is blinding necessary?Alejandro R. Jadad, R Andrew Moore, Dawn Carroll — 1996
• Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis.Peter C Gøtzsche — 1989
• The scandal of poor medical researchRaj Bhopal — 1994
• Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials.Klaus‐Peter Schulz — 1995
• Use of check lists in assessing the statistical content of medical studies.Martin J. Gardner, David Machin, Moray J. Campbell — 1986
• Clinical research in general medical journals: a 30-year perspective.Robert H. Fletcher, Suzanne W. Fletcher — 1979
• Identifying relevant studies for systematic reviewsMike Clarke, Liz Greaves — 1995
• Use of brand names in place of generics.Joseph H. Davis — 1995
• Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecologyK. F Schulz, David A. Grimes, Douglas G. Altman — 1996
• Ascorbic acid for the common cold. A prophylactic and therapeutic trial.Thomas R. Karlowski, T C Chalmers, Lawrence D. Frenkel — 1975

Cited by

• The proper sample size in clinical orthopedic trialsD. R. C. Brocai, M. Lukoschek, Morghan Hartmann — 1998
• A systematic review of comparisons of effect sizes derived from randomised and non-randomised studies.MacLehose, Reeves, Gill Harvey — 2000
• Distinguishing between “no evidence of effect” and “evidence of no effect” in randomised controlled trials and other comparisons芽生 齋藤 — 1999
• Practice guidelines developed by specialty societies: the need for a critical appraisal.玲子 岸, 洋子 片倉, 潤子 湯浅 — 2000
• Evidence-based pediatric infectious diseases.Пшишок Адам Асланович — 2000
• Duration of Symptoms and Plasma Cytokine Levels in Patients with the Common Cold Treated with Zinc AcetateS.A. Staurianidis, G.A. Keiyan, A.A. Kutsya — 2000
• Reporting on methods of subgroup analysis in clinical trials: a survey of four scientific journals.Lindsey E Mitchell — 2001
• Effect of electrical stimulation on musculoskeletal systems; A meta‐analysis of controlled clinical trialsKenneth R. White — 2002
• Re: Chan et al. A double‐blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients. Int J Geriatr Psychiatry 16: 1156 ‐ 1162Bas Savenije — 2002
• Evidence based evaluation of immuno-coagulatory interventions in critical care.Arash Afshari — 2011
• Reporting in randomized clinical trials improved after adoption of the CONSORT statement.John Jacobs Holden — 2007
• Reducing maladaptive weight management practices: developing a psychoeducational intervention program.唐礼瑞, 郭涛, 陶艳艳 — 2007
• The problem of bias in medical research and its relationship with medical educationM. Basso — 2005
• Randomized Phase III controlled trials of therapy in malignant glioma: where are we after 40 years?Elaine Anderson, Robin Grant, Steff Lewis — 2008
• Binge eating disorder pharmacotherapy clinical trails--who is left out?Andrée Paradis — 2009
• Evolution of the randomized controlled trial in oncology over three decades.Richmond F. Brown — 2008
• Application of the Consort Statement to Randomized Controlled Trials Comparing Endoscopic and Open Carpal Tunnel ReleaseАникин Даниил Александрович — 2006
• CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials光一郎 道本, 智幸 鈴木 — 2010
• Induction and maintenance treatment of proliferative lupus nephritis: a meta-analysis of randomized controlled trials.Lorna Henderson, Philip Masson, Jonathan C. Craig — 2013
• A Systematic Review of the Reporting of Adverse Events Associated With Medical Herb Use Among ChildrenErinna Tanoch — 2013

Related papers

• Expanding the CONSORT Figure: Increasing Transparency in Reporting on External Validity.Russell E. Glasgow, Amy G. Huebschmann, Ross C. Brownson — 2018
• Situational Enhancement of Design Validity: The Case of Training Evaluation at the World Bank InstituteWm. Albert Eckert — 2000
• A More Rigorous QUASI-Experimental Alternative to the One-Group Pretest-Posttest DesignCraig Johnson — 1986
• Situational Enhancement of Design Validity: The Case of Training Evaluation at the World Bank Institute:Wojciech Eckert — 2000
• 7. ASSESSING THE VALIDITY OF MINIMAL PHENOTYPING: A UK BIOBANK STUDYBenjamin Woolf, Claire M. A. Haworth, Oliver S. P. Davis — 2021